52 related articles for article (PubMed ID: 1559663)
21. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
[TBL] [Abstract][Full Text] [Related]
22. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
[TBL] [Abstract][Full Text] [Related]
23. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
[TBL] [Abstract][Full Text] [Related]
24. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
Dodd SW; Havel HA; Kovach PM; Lakshminarayan C; Redmon MP; Sargeant CM; Sullivan GR; Beals JM
Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
[TBL] [Abstract][Full Text] [Related]
25. Pluronic
Sultan MH; Mahdi WA; Kwon YM
Bioimpacts; 2021; 11(1):59-64. PubMed ID: 33469509
[No Abstract] [Full Text] [Related]
26. A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.
Beavis RC; Kneirman MD; Sharknas D; Heady MA; Frank BH; DeFelippis MR
J Pharm Sci; 1999 Mar; 88(3):331-6. PubMed ID: 10052992
[TBL] [Abstract][Full Text] [Related]
27. Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs.
Deckert T; Hansen B; Kølendorf K; Poulsen JS; Smith M
Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):30-7. PubMed ID: 6751023
[TBL] [Abstract][Full Text] [Related]
28. Clinical pharmacologic studies with human insulin (recombinant DNA).
Galloway JA; Root MA; Bergstrom R; Spradlin CT; Howey DC; Fineberg SE; Jackson RL
Diabetes Care; 1982; 5 Suppl 2():13-22. PubMed ID: 6765524
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with a new modified protamine insulin (NPH-50).
GABRIELE AJ; MARBLE A
Am J Dig Dis; 1949 Jun; 16(6):197-206. PubMed ID: 18129669
[No Abstract] [Full Text] [Related]
30. Computational Approach to Elucidating Insulin-Protamine Binding Interactions and Dynamics in Insulin NPH Formulations.
Rohilla KK; Pandey MK
ACS Omega; 2024 Jan; 9(4):4857-4869. PubMed ID: 38313521
[TBL] [Abstract][Full Text] [Related]
31. [New form of insulin: crystallized protamine insulin (NPH 50)].
RUDOLF M
Concours Med; 1951 Nov; 73(45):3755-7. PubMed ID: 14887229
[No Abstract] [Full Text] [Related]
32. [Insulin with retarded and prolonged action: a new preparation: crystallized protamine insulin NPH 50].
AUBERTIN E
J Med Bord; 1951 Jul; 128(7):716-20. PubMed ID: 14861556
[No Abstract] [Full Text] [Related]
33. Modified protamine insulin (NPH-50) a clinical report.
WHITE P
J Am Med Assoc; 1949 Oct; 141(5):312-4. PubMed ID: 18148369
[No Abstract] [Full Text] [Related]
34. Some investigations on the absorption mechanism of protamine insulin.
BANG HO
Acta Pharmacol Toxicol (Copenh); 1946; 2(1):79-88. PubMed ID: 21028326
[No Abstract] [Full Text] [Related]
35. Human insulin crystals.
Schade DS; DeLongo-Davis J
JAMA; 1985 Apr; 253(16):2417. PubMed ID: 3884854
[No Abstract] [Full Text] [Related]
36. The Use of Protamine Insulin.
Nixon JA
Bristol Med Chir J (1883); 1938; 55(208):121-131. PubMed ID: 28897790
[No Abstract] [Full Text] [Related]
37. Anterior chest wall deformities and congenital heart disease.
Shamberger RC; Welch KJ; Castaneda AR; Keane JF; Fyler DC
J Thorac Cardiovasc Surg; 1988 Sep; 96(3):427-32. PubMed ID: 3411988
[TBL] [Abstract][Full Text] [Related]
38. Structural characterization of insulin NPH formulations.
Norrman M; Hubálek F; Schluckebier G
Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
[TBL] [Abstract][Full Text] [Related]
39. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
Yanagisawa K
Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
